Ipex Capital

Ipex Capital is a venture capital firm based in the United Kingdom that specializes in early-stage investments within the life sciences, healthcare, nanotechnology, and information technology sectors. Originally established as the venture arm of PA Consulting Group, it became an independent entity in 2008 to focus on commercializing high-value intellectual property and incubating disruptive technologies. The firm is well-known for its track record in scaling science-based businesses, with notable historical exits including Meridica (sold to Pfizer) and UbiNetics. Ipex Capital typically provides seed and early-stage financing, working closely with entrepreneurs to transition innovative concepts from the laboratory to the global market.